$TherapeuticsMD(TXMD.US)$See some improvements in earnings but most importantly why I’ve got my attention here is the following statement from the company! ( said that it is exploring strategic alternatives for the company, which could include a business combination or sale of assets. ) Would love to see a big Pharma swoop in a buy! Thats why it has my attention! The company also released its Q3 financial report, posting a net loss from continuing operations of $0.13 per share...
TherapeuticsMD股票討論區
Watching closely
The company also released its Q3 financial report, posting a net loss from continuing operations of $0.13 per share...
利潤表顯示2022年的利潤絕大部分來自1.11億的停止經營利潤,是不可持續的,持續經營利潤僅107萬,按目前4433萬市值計算,市盈率達到41,可以再觀察幾個季度的情況再做判斷。
Go up
Dip buy watch
Looks promising
專欄Top upgrades and downgrades on 6/7
• $美源伯根(ABC.US)$ : Deutsche Bank Upgrades to Buy from Hold - PT $178 (from $167)
• $Arch Resources(ARCH.US)$ : Jefferies Upgrades to Buy From Hold - PT $225 (from $160)
• $必和必拓(BHP.US)$ : Jefferies Upgrades to Buy From Hold - PT $82 (from $72)
• $Peabody Energy(BTU.US)$ : Jefferies Upgrades to Buy From Hold - PT $36 (from $25)
• $Warrior Met Coal(HCC.US)$ : Jefferies Upgrades to Buy From Hold - PT $50 (from $36)
• $自由全球-A(LBTYA.US)$ : Berenbe...
暫無評論